Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,713 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 686
Recruiting: 381
Ph III recruiting: 45
Growth YoY: +8.5%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (278)

clinicaltrialsPublishedShowing 201–202 of 202 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01075607	Lymph Fluid and Blood Collection for Identification of Novel Biomarkers	terminated	—	50	Indiana UniversityOTHER	1	Mar 28, 2012	clinicaltrials
NCT00461344	Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer	terminated	Phase 2	20	SanofiINDUSTRY	0	Apr 3, 2008	clinicaltrials